The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model

dc.contributor.author	Mumusoglu, S.
dc.contributor.author	Turan, V.
dc.contributor.author	Uckan, H.
dc.contributor.author	Suzer, A.
dc.contributor.author	Sokmensuer, L.K.
dc.contributor.author	Bozdag, G.
dc.date.accessioned	2021-12-21T08:41:03Z
dc.date.available	2021-12-21T08:41:03Z
dc.date.issued	2018
dc.identifier.issn	19337191
dc.identifier.uri	https://doi.org/10.1177/1933719117741376
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1300
dc.description.abstract	In animal studies, intravenous continuous infusion or peritoneal injection of sphingosine-1-phosphate (S1P) has been shown to decrease chemotherapy- and radiotherapy-induced apoptosis on primordial follicles. Although a long-acting oral form of an S1P ana
dc.description.sponsorship	The author(s) disclosed financial support for the research, authorship, and/or publication of this article: Hacettepe University Foundation of Scientific Research supports this research (Project number THD-2015-6931). This research was partially supported
dc.language.iso	English
dc.publisher	SAGE Publications Inc.
dc.title	The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model
dc.type	Article
dc.relation.journal	Reproductive Sciences
dc.identifier.issue	9
dc.identifier.startpage	1330
dc.identifier.endpage	1335
dc.identifier.volume	25
dc.identifier.doi	10.1177/1933719117741376
dc.relation.issue	9
dc.relation.volume	25

Files in this item

Files	Size	Format	View
There are no files associated with this item.